United States · FDA National Drug Code directory
Fulvestrant
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68001-626_3ac255a1-c4ba-46f2-e063-6294a90a0628
- Product NDC
- 68001-626
- Form
- INJECTION
- Composition / generic term
- Fulvestrant
- Labeler
- BluePoint Laboratories.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250117
- Source listing expiry
- 20261231
Source-listed ingredients
- FULVESTRANT — 50 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 SYRINGE in 1 CARTON (68001-626-85) / 5 mL in 1 SYRINGE (68001-626-86) · 68001-626-85
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →